Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss	$ (8,173,612)	$ (12,168,918)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	34,558	3,394
Amortization of intangible assets	203,388
Stock-based compensation	4,505,545	6,497,789
Issuance of common stock for services	20,000	1,055,502
Accrued interest income on notes receivable from third party	(708)
Change in fair value of financial instruments	21,842	(81,398)
Change in earn-out liability	(37,270)
Provision for bad debt	199,087
Changes in operating assets and liabilities:
Accounts receivable	(27,826)
Customer short term notes receivable	(570,946)
Long term notes receivable	(657,967)
Deferred revenue	368,477
Prepaid insurance	(12,144)	22,052
Other assets	(4,300)
Amounts on deposits with or due from merchant processor	(33,345)	(32,230)
Accounts payable and accrued liabilities	(567,663)	(1,833,085)
Accrued deferred personnel compensation	(146,145)	(385,403)
Net cash used in operating activities	(4,879,029)	(6,922,297)
Cash flows from investing activities:
Acquisition of Intellectual Capital Management LLC ("SMS")	(1,000,293)
Payment of deferred acquisition payable - Intellectual Capital Mgmt, LLC	(375,000)
Acquisition of TechXpress Web business	(460,401)
Issuance of notes receivable to third party	(410,000)
Sale of property and equipment	251	2,505
Payment on long term liabilities (SBA Loans)	(226,522)
Purchase of property and equipment	(396,447)
Net cash (used in) provided by investing activities	(2,868,412)	2,505
Cash flows from financing activities:
Net proceeds from issuance of preferred stock, common stock, and warrants	10,472,003
Net proceeds from exercise of warrants to purchase common stock		1,384,973
Net cash provided by financing activities	10,472,003	1,384,973
Net increase (decrease) in cash and cash equivalents	2,724,562	(5,534,819)
Cash and cash equivalents at beginning of the period	497,313	6,605,567
Cash and cash equivalents at end of the period	$ 3,221,875	$ 1,070,748
Supplemental Cash Flow Information [Abstract]
Conversion, preferred shares converted	333,434
Conversion, common shares issued	1,333,736
Shares issued for notes payable conversion	226,655